Enhancing TIL Therapy Efficacy through Patient Stratification & Selection by Identifying Suitable Biomarkers

Time: 1:30 pm
day: Pre-Conference Workshop Day


It has become apparent that some patient populations respond better to TIL therapies compared to others. Therefore, it is vital to develop methods to easily identify patients where TIL will elicit higher efficacies. This in depth workshop session seeks to discuss methods to discover markers of TIL efficacy and share biomarker of response development to further increase TIL therapy efficacy in the future.

  • Detecting patients with beneficial responses to TIL therapy to identify markers which translate to TIL activity and efficacy in vivo
  • Uncovering biomarkers which translate across beneficial responses
  • Leveraging biomarkers of response to classify patient populations with increased benefit to TIL therapy
  • TIL expansion and contraction features associated with response and persistence
  • Building data and AI/ML infrastructure for translational and clinical correlative analysis